Inventor · disambiguated record

Francesco G. Salituro

Also filed as: SALITURO FRANCESCO · SALITURO FRANCESCO G · SALITURO FRANCESCO GERALD · SALITURO JR FRANCESCO G

177 granted patents·109 pending applications·2,674 citations·filing 1989–2025

99Inventor score

Technology areasA61P C07J C07D A61K C07C

Files withSAGE THERAPEUTICS INC144 VERTEX PHARMA49 AGIOS PHARMACEUTICALS INC28 SALITURO FRANCESCO G10 MERRELL DOW PHARMA8

Top patents by PatentIndex Score

286 records

0199US11530237B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·9 cites·4 claims
0299US11149057B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Oct 19, 2021·9 cites·33 claims
0399US10723758B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·20 cites·2 claims
0499US10246482B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 2, 2019·38 cites·85 claims
0598US11905309B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Feb 20, 2024·5 cites·18 claims
0698US11878995B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 23, 2024·5 cites·16 claims
0798US11613556B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 28, 2023·6 cites·20 claims
0898US11542297B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 3, 2023·9 cites·28 claims
0998US11241446B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·12 cites·15 claims
1098US11149054B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Oct 19, 2021·14 cites·8 claims
1198US11111266B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Sep 7, 2021·15 cites·25 claims
1298US11104701B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Aug 31, 2021·16 cites·24 claims
1398US10870677B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·13 cites·1 claims
1498US10696712B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jun 30, 2020·21 cites·3 claims
1598US10259840B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 16, 2019·30 cites·3 claims
1698US10227375B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·33 cites·4 claims
1798US9512165B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·71 cites·2 claims
1898US8785450B2Therapeutic compounds and compositionsSALITURO FRANCESCO G·Filed 2010·Granted Jul 22, 2014·45 cites·51 claims
1997US12060386B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2023·Granted Aug 13, 2024·3 cites·10 claims
2097US11926646B2C7 substituted oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 12, 2024·5 cites·11 claims
2197US11884697B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·6 cites·27 claims
2297US11780875B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Oct 10, 2023·4 cites·20 claims
2397US11732000B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Aug 22, 2023·6 cites·12 claims
2497US11643434B2Neuroactive steroids and compositions thereofSAGE THERAPEUTICS INC·Filed 2020·Granted May 9, 2023·9 cites·25 claims
2597US11498940B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·8 cites·30 claims
2697US11407782B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Aug 9, 2022·5 cites·22 claims
2797US10822370B219-nor neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Nov 3, 2020·13 cites·24 claims
2897US10774108B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2015·Granted Sep 15, 2020·12 cites·18 claims
2997US10759828B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Sep 1, 2020·15 cites·1 claims
3097US10745436B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Aug 18, 2020·9 cites·30 claims
3197US10342810B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·17 cites·16 claims
3297US10201550B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·23 cites·2 claims
3397US10172871B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·20 cites·12 claims
3497US9725481B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Aug 8, 2017·46 cites·26 claims
3597US9512107B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 6, 2016·25 cites·9 claims
3697US9365611B219-NOR neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·49 cites·25 claims
3797US8889667B2Therapeutic compounds and compositionsSALITURO FRANCESCO G·Filed 2011·Granted Nov 18, 2014·28 cites·11 claims
3897US8742119B2Pyruvate kinase M2 modulators, therapeutic compositions and related methods of useSALITURO FRANCESCO G·Filed 2011·Granted Jun 3, 2014·39 cites·14 claims
3997US7767816B2Azaindoles useful as inhibitors of janus kinasesVERTEX PHARMA·Filed 2007·Granted Aug 3, 2010·44 cites·53 claims
4097US7507826B2Azaindoles useful as inhibitors of JAK and other protein kinasesVERTEX PHARMA·Filed 2005·Granted Mar 24, 2009·55 cites·17 claims
4197US6689778B2Inhibitors of Src and Lck protein kinasesVERTEX PHARMA·Filed 2002·Granted Feb 10, 2004·109 cites·17 claims
4297US5945418AInhibitors of p38VERTEX PHARMA·Filed 1997·Granted Aug 31, 1999·156 cites·25 claims
4396US12129276B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·2 cites·20 claims
4496US11945836B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·3 cites·20 claims
4596US11851457B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·4 cites·18 claims
4696US11344563B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted May 31, 2022·8 cites·20 claims
4796US11279730B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Mar 22, 2022·5 cites·13 claims
4896US11147877B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Oct 19, 2021·8 cites·12 claims
4996US11046728B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·8 cites·14 claims
5096US10029987B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Jul 24, 2018·9 cites·24 claims

Showing the top 50 of 286 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Francesco G. Salituro files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →